Tezruly Solution
Product Images NDC 70954-592

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tezruly (NDC 70954-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (Image 1)

A line graph comparing the effects of Terazosin versus placebo over a 3-month period. The x-axis represents months, while the y-axis shows change measurements. Two data series are plotted with error bars: one for Terazosin and one for placebo, indicating sample sizes of 54 and 55, respectively.*

FDA Label Image

Image-2 (Image 2)

A line graph comparing the effect of Terazosin solution and placebo over three months. The y-axis measures mL/sec and the x-axis represents time in months. Two lines, labeled TERAZOSIN and PLACEBO, show increasing then stabilizing trends with error bars, based on sample sizes of 52 and 54 respectively.*

FDA Label Image

Image-3 (Image 3)

A line graph depicting the mean change from baseline over 30 months, with data points marked at regular intervals and asterisks indicating significance. The x-axis represents time in months, and the y-axis shows mean change values ranging approximately from 0 to -6.*

FDA Label Image

Image-4 (Image 4)

A line chart depicting the mean change from baseline over a 30-month period. The x-axis is labeled with time in months from 0 to 30, and the y-axis shows mean change values ranging from 0.0 to 4.5. Data points are connected by a line with error bars, and several points are marked with asterisks indicating statistical significance.*

FDA Label Image

Label (Label)

Label for TEZRULY (terazosin) Oral Solution 1 mg/mL, a prescription oral liquid medication. The label includes storage instructions, a warning to keep the medication out of reach of children, and pharmacist dispensing instructions. Distributed by ANI Pharmaceuticals, Inc., Baudette, MN. The container size indicated is 150 mL.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Terazosin hydrochloride dihydrate, the active ingredient in TEZRULY oral solution by ANI Pharmaceuticals, Inc. The structure shows the molecular arrangement including methoxy groups, piperazine ring, and tetrahydrofuran ester moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.